

| Á¦¸ñ | [MFDS] ÀǾàǰµîÀÇ ¾ÈÁ¤¼º½ÃÇè±âÁØ ÀϺΠ°³Á¤ °í½Ã | ||
|---|---|---|---|
| µî·ÏÀÏ | 2016-06-24 | Á¶È¸¼ö | 1,485 |
| ÷ºÎÆÄÀÏ | ÀǾàǰµîÀÇ ¾ÈÁ¤¼º½ÃÇè±âÁØ Á¦2016-46È£.hwp | ||
| ³»¿ë | ½Ä¾àó¿¡¼ ÀǾàǰµîÀÇ ¾ÈÁ¤¼º½ÃÇè±âÁØ(Á¦2016-46È£, 2016.6.14) À» ÀϺΠ°³Á¤ °í½ÃÇÏ¿´½À´Ï´Ù. ------------------------------------------------------------------------------------------------------------ ÀǾàǰµîÀÇ ¾ÈÁ¤¼º½ÃÇè±âÁØ ÀϺΰ³Á¤°í½Ã ------------------------------------------------------------------------------------------------------------ °¨»çÇÕ´Ï´Ù. |
||
| ÀÌÀü±Û | [MFDS]Á¦ÇüÀÌ ´Ù¸¥ µ¿ÀÏ Á¦Á¶°øÁ¤ ÀǾàǰÀÇ Á¦Á¶½Ã¼³ °øµ¿»ç¿ë °ËÅäÁöħ(°³Á¤) |
|---|
| ´ÙÀ½±Û | [FDA] MAPP 5016.1 Applying ICH Q8(R2), Q9, and Q10 Principles to CMC Review |
|---|